Helicobacter pylori and autoimmune diseases

Oral Diseases

Volumn 17, Issue 7, 2011, Pages 621-627

  Hasni, Sarfaraz A ^a   Ippolito, A ^a   Illei, G G ^b  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b National Institutes of Dental and Craniofacial Research and Health   (United States)

Author keywords

Autoimmunity; Etiology; Infection; Lymphoma

Indexed keywords

ATROPHIC GASTRITIS; AUTOIMMUNE DISEASE; DISEASE COURSE; ENVIRONMENTAL EXPOSURE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNE RESPONSE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; VIRUS INFECTION;

ANTIBODIES, BACTERIAL; AUTOIMMUNE DISEASES; GENETIC PREDISPOSITION TO DISEASE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HOST-PATHOGEN INTERACTIONS; HUMANS; LYMPHOCYTES; MOLECULAR MIMICRY;

EID: 80052572105     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2011.01796.x     Document Type: Review

References (69)

1. +- adenosine triphosphatase in human gastric autoimmunity. J Exp Med 198: 1147-1156.
2. Aragona P, Magazzu G, Macchia G et al (1999). Presence of antibodies against Helicobacter pylori and its heat-shock protein 60 in the serum of patients with Sjogren's syndrome. J Rheumatol 26: 1306-1311.
3. Asahi M, Azuma T, Ito S et al (2000). Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells. J Exp Med 191: 593-602.
4. Azevedo NF, Huntington J, Goodman KJ (2009). The epidemiology of Helicobacter pylori and public health implications. Helicobacter 14(Suppl 1): 1-7.
5. Bach JF (2005). Infections and autoimmune diseases. J Autoimmun 25(Suppl): 74-80.
6. Bazzoli F (2001). Key points from the revised Maastricht Consensus Report: the impact on general practice. Eur J Gastroenterol Hepatol 13(Suppl 2): S3-S7.
7. Blaser MJ (1997). Ecology of Helicobacter pylori in the human stomach. J Clin Invest 100: 759-762.
8. Brown LM (2000). Helicobacter pylori: epidemiology and routes of transmission. Epidemiol Rev 22: 283-297.
9. Bruce MG, Maaroos HI (2008). Epidemiology of Helicobacter pylori infection. Helicobacter 13(Suppl 1): 1-6.
10. Burgers R, Schneider-Brachert W, Reischl U et al (2008). Helicobacter pylori in human oral cavity and stomach. Eur J Oral Sci 116: 297-304.
11. Chey WD, Wong BC (2007). American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol 102: 1808-1825.
12. Cines DB, Blanchette VS (2002). Immune thrombocytopenic purpura. N Engl J Med 346: 995-1008.
13. Dowsett SA, Kowolik MJ (2003). Oral Helicobacter pylori: can we stomach it? Crit Rev Oral Biol Med 14: 226-233.
14. El Miedany YM, Baddour M, Ahmed I, Fahmy H (2005). Sjogren's syndrome: concomitant H. pylori infection and possible correlation with clinical parameters. Joint Bone Spine 72: 135-141.
15. Emilia G, Longo G, Luppi M et al (2001). Helicobacter pylori eradication can induce platelet recovery in idiopathic thrombocytopenic purpura. Blood 97: 812-814.
16. Everhart JE (2000). Recent developments in the epidemiology of Helicobacter pylori. Gastroenterol Clin North Am 29: 559-578.
17. Fan X, Gunasena H, Cheng Z et al (2000). Helicobacter pylori urease binds to class II MHC on gastric epithelial cells and induces their apoptosis. J Immunol 165: 1918-1924.
18. Getts MT, Miller SD (2010). 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: triggering of autoimmune diseases by infections. Clin Exp Immunol 160: 15-21.
19. Goodman KJ, Correa P, Tengana Aux HJ et al (1996). Helicobacter pylori infection in the Colombian Andes: a population-based study of transmission pathways. Am J Epidemiol 144: 290-299.
20. Guruge JL, Falk PG, Lorenz RG et al (1998). Epithelial attachment alters the outcome of Helicobacter pylori infection. Proc Natl Acad Sci USA 95: 3925-3930.
21. Harris PR, Smythies LE, Smith PD, Dubois A (2000). Inflammatory cytokine mRNA expression during early and persistent Helicobacter pylori infection in nonhuman primates. J Infect Dis 181: 783-786.
22. Hessey SJ, Spencer J, Wyatt JI et al (1990). Bacterial adhesion and disease activity in Helicobacter associated chronic gastritis. Gut 31: 134-138.
23. Howden CW, Hunt RH (1998). Guidelines for the management of Helicobacter pylori infection. Ad hoc committee on Practice Parameters of the American College of Gastroenterology. Am J Gastroenterol 93: 2330-2338.
24. Ishikawa N, Fuchigami T, Matsumoto T et al (2002). Helicobacter pylori infection in rheumatoid arthritis: effect of drugs on prevalence and correlation with gastroduodenal lesions. Rheumatology (Oxford) 41: 72-77.
25. Iwai H, Nakamichi N, Nakae K et al (2009). Parotid mucosa-associated lymphoid tissue lymphoma regression after Helicobacter pylori eradication. Laryngoscope 119: 1491-1494.
26. Jackson L, Britton J, Lewis SA et al (2009). A population-based epidemiologic study of Helicobacter pylori infection and its association with systemic inflammation. Helicobacter 14: 108-113.
27. Janssen M, Dijkmans BA, van der Sluys FA et al (1992). Upper gastrointestinal complaints and complications in chronic rheumatic patients in comparison with other chronic diseases. Br J Rheumatol 31: 747-752.
28. Kim SY, Lee YC, Kim HK, Blaser MJ (2006). Helicobacter pylori CagA transfection of gastric epithelial cells induces interleukin-8. Cell Microbiol 8: 97-106.
29. Klausz G, Tiszai A, Lenart Z et al (2004). Helicobacter pylori-induced immunological responses in patients with duodenal ulcer and in patients with cardiomyopathies. Acta Microbiol Immunol Hung 51: 311-320.
30. Kuipers EJ, Pena AS, van Kamp G et al (1993). Seroconversion for Helicobacter pylori. Lancet 342: 328-331.
31. Kuwana M, Ikeda Y (2006). Helicobacter pylori and immune thrombocytopenic purpura: unsolved questions and controversies. Int J Hematol 84: 309-315.
32. Liebman H (2007). Other immune thrombocytopenias. Semin Hematol 44: S24-S34.
33. Malaty HM, El-Kasabany A, Graham DY et al (2002). Age at acquisition of Helicobacter pylori infection: a follow-up study from infancy to adulthood. Lancet 359: 931-935.
34. Malfertheiner P, Megraud F, O'Morain C et al (2007). Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 56: 772-781.
35. Marshall BJ, Warren JR (1984). Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1: 1311-1315.
36. Matsukawa Y, Asai Y, Kitamura N, Sawada S, Kurosaka H (2005). Exacerbation of rheumatoid arthritis following Helicobacter pylori eradication: disruption of established oral tolerance against heat shock protein? Med Hypotheses 64: 41-43.
37. McColl KE (2010). Clinical practice. Helicobacter pylori infection. N Engl J Med 362: 1597-1604.
38. McGee DJ, Mobley HL (1999). Mechanisms of Helicobacter pylori infection: bacterial factors. Curr Top Microbiol Immunol 241: 155-180.
39. Meron MK, Amital H, Shepshelovich D et al (2010). Infectious aspects and the etiopathogenesis of rheumatoid arthritis. Clin Rev Allergy Immunol 38: 287-291.
40. Odenbreit S, Puls J, Sedlmaier B, Gerland E, Fischer W, Haas R (2000). Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 287: 1497-1500.
41. Parsonnet J, Hansen S, Rodriguez L et al (1994). Helicobacter pylori infection and gastric lymphoma. N Engl J Med 330: 1267-1271.
42. Parsonnet J, Shmuely H, Haggerty T (1999). Fecal and oral shedding of Helicobacter pylori from healthy infected adults. JAMA 282: 2240-2245.
43. Peek RM Jr, Fiske C, Wilson KT (2010). Role of innate immunity in Helicobacter pylori-induced gastric malignancy. Physiol Rev 90: 831-858.
44. Poole BD, Templeton AK, Guthridge JM, Brown EJ, Harley JB, James JA (2009). Aberrant Epstein-Barr viral infection in systemic lupus erythematosus. Autoimmun Rev 8: 337-342.
45. Pordeus V, Szyper-Kravitz M, Levy RA, Vaz NM, Shoenfeld Y (2008). Infections and autoimmunity: a panorama. Clin Rev Allergy Immunol 34: 283-299.
46. Prakobphol A, Boren T, Ma W, Zhixiang P, Fisher SJ (2005). Highly glycosylated human salivary molecules present oligosaccharides that mediate adhesion of leukocytes and Helicobacter pylori. Biochemistry 44: 2216-2224.
47. Robinson K, Argent RH, Atherton JC (2007). The inflammatory and immune response to Helicobacter pylori infection. Best Pract Res Clin Gastroenterol 21: 237-259.
48. Royer B, Cazals-Hatem D, Sibilia J et al (1997). Lymphomas in patients with Sjogren's syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses. Blood 90: 766-775.
49. Sawalha AH, Schmid WR, Binder SR, Bacino DK, Harley JB (2004). Association between systemic lupus erythematosus and Helicobacter pylori seronegativity. J Rheumatol 31: 1546-1550.
50. Scott DL, Wolfe F, Huizinga TW (2010). Rheumatoid arthritis. Lancet 376: 1094-1108.
51. Seriolo B, Cutolo M, Zentilin P, Savarino V (2001). Helicobacter pylori infection in rheumatoid arthritis. J Rheumatol 28: 1195-1196.
52. Showji Y, Nozawa R, Sato K, Suzuki H (1996). Seroprevalence of Helicobacter pylori infection in patients with connective tissue diseases. Microbiol Immunol 40: 499-503.
53. Song Q, Haller B, Ulrich D, Wichelhaus A, Adler G, Bode G (2000). Quantitation of Helicobacter pylori in dental plaque samples by competitive polymerase chain reaction. J Clin Pathol 53: 218-222.
54. Stasi R, Rossi Z, Stipa E, Amadori S, Newland AC, Provan D (2005). Helicobacter pylori eradication in the management of patients with idiopathic thrombocytopenic purpura. Am J Med 118: 414-419.
55. Steen KS, Lems WF, Visman IM et al (2009). The effect of Helicobacter pylori eradication on C-reactive protein and the lipid profile in patients with rheumatoid arthritis using chronic NSAIDs. Clin Exp Rheumatol 27: 170.
56. Stein M, Rappuoli R, Covacci A (2000). Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation. Proc Natl Acad Sci USA 97: 1263-1268.
57. Suchy BH, Wolf SR (2000). Bilateral mucosa-associated lymphoid tissue lymphoma of the parotid gland. Arch Otolaryngol Head Neck Surg 126: 224-226.
58. Suerbaum S, Michetti P (2002). Helicobacter pylori infection. N Engl J Med 347: 1175-1186.
59. Sundrud MS, Torres VJ, Unutmaz D, Cover TL (2004). Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion. Proc Natl Acad Sci USA 101: 7727-7732.
60. Suzuki T, Matsushima M, Masui A et al (2005). Effect of Helicobacter pylori eradication in patients with chronic idiopathic thrombocytopenic purpura-a randomized controlled trial. Am J Gastroenterol 100: 1265-1270.
61. Tanaka E, Singh G, Saito A et al (2005). Prevalence of Helicobacter pylori infection and risk of upper gastrointestinal ulcer in patients with rheumatoid arthritis in Japan. Mod Rheumatol 15: 340-345.
62. Theander E, Nilsson I, Manthorpe R, Jacobsson LT, Wadstrom T (2001). Seroprevalence of Helicobacter pylori in primary Sjogren's syndrome. Clin Exp Rheumatol 19: 633-638.
63. Tindberg Y, Blennow M, Granstrom M (1999). Clinical symptoms and social factors in a cohort of children spontaneously clearing Helicobacter pylori infection. Acta Paediatr 88: 631-635.
64. Vare PO, Heikius B, Silvennoinen JA et al (2001). Seroprevalence of Helicobacter pylori infection in inflammatory bowel disease: is Helicobacter pylori infection a protective factor? Scand J Gastroenterol 36: 1295-1300.
65. Walz A, Odenbreit S, Stuhler K et al (2009). Identification of glycoprotein receptors within the human salivary proteome for the lectin-like BabA and SabA adhesins of Helicobacter pylori by fluorescence-based 2-D bacterial overlay. Proteomics 9: 1582-1592.
66. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG (1991). Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 338: 1175-1176.
67. Xia HH, Talley NJ (1997). Natural acquisition and spontaneous elimination of Helicobacter pylori infection: clinical implications. Am J Gastroenterol 92: 1780-1787.
68. Yamanishi S, Iizumi T, Watanabe E et al (2006). Implications for induction of autoimmunity via activation of B-1 cells by Helicobacter pylori urease. Infect Immun 74: 248-256.
69. Zentilin P, Seriolo B, Dulbecco P et al (2002). Eradication of Helicobacter pylori may reduce disease severity in rheumatoid arthritis. Aliment Pharmacol Ther 16: 1291-1299.